Suppr超能文献

类风湿关节炎高患病率的奇珀瓦印第安亚人群体的HLA - DR特征分析。

HLA-DR characterization of a Chippewa Indian subpopulation with high prevalence of rheumatoid arthritis.

作者信息

Bias W B, Hsu S H, Pollard M K, Harvey J, Lotze M T, Arnett F C, Stevens M B

出版信息

Hum Immunol. 1981 Mar;2(2):155-63. doi: 10.1016/0198-8859(81)90062-8.

Abstract

The adult population (N = 227) of a Chippewa Indian reservation in central Minnesota is characterized by a high prevalence of arthropathy with 7.1% having rheumatoid arthritis (RA). In a prospective study 168 reservation residents (74%) were evaluated. Complete HLA typing identified 57 haplotypes, many of which probably arose via HLA-A/B or B/D recombination. The number of founder haplotypes appeared to be about 20. The population frequency of DR4 (including DRw9, formerly designated 4 X 7) was 67%; for RA it was 100% (p less than 0.05). Apparent DR4 homozygotes, a number of the RA patients, and family members were selected for further study in a mixed lymphocyte culture (MLC) test and with 8th International Workshop cellular and serologic reagents. In MLC with homozygous typing cells (HTC), non of the DR4+ cells typed for any known HLA-D specificity, although they reacted to all DR4 antisera on the local panel. However, 8th International Workshop DR antisera revealed patterns of reactivity with non-DRf4 reagents consistent with the MLC. A minimum of three DR4 variants, one DRw9 variant, and a specificity related to both DR4 and DR2 are required to explain both the cellular and serologic reactions. For the present, we are designating the antigens as DR4.1chip, DR4.2chip, DR4.3chip, DR9chip, and DR(2 X 4)chip. No single variant of DR4 was characteristic of the RA patients in this Amer-indian population.

摘要

明尼苏达州中部一个齐佩瓦印第安人保留地的成年人口(N = 227)的特点是关节病患病率高,其中7.1%患有类风湿性关节炎(RA)。在一项前瞻性研究中,对168名保留地居民(74%)进行了评估。完整的HLA分型确定了57种单倍型,其中许多可能是通过HLA - A/B或B/D重组产生的。奠基者单倍型的数量似乎约为20种。DR4(包括DRw9,以前称为4X7)的人群频率为67%;在RA患者中为100%(p小于0.05)。选择明显的DR4纯合子、一些RA患者及其家庭成员,使用混合淋巴细胞培养(MLC)试验以及第8届国际研讨会的细胞和血清学试剂进行进一步研究。在与纯合分型细胞(HTC)进行的MLC中,尽管DR4 +细胞对本地面板上的所有DR4抗血清都有反应,但没有一个细胞被分型为任何已知的HLA - D特异性。然而,第8届国际研讨会的DR抗血清显示,与非DR4试剂的反应模式与MLC一致。至少需要三种DR4变体、一种DRw9变体以及一种与DR4和DR2都相关的特异性来解释细胞和血清学反应。目前,我们将这些抗原命名为DR4.1chip、DR4.2chip、DR4.3chip、DR9chip和DR(2X4)chip。在这个美洲印第安人群体中,没有单一的DR4变体是RA患者所特有的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验